Gilead Sciences, Inc. today presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapavir, the company's injectable HIV-1 capsid inhibitor, ...
The latest news on President Donald Trump’s administration as the House is expected to vote on a continuing resolution to ...
Some disappointed Hulk Hogan fans say they were turned away empty-handed last week after standing in line and waiting for hours for a promised meet-and-greet with the entertainment icon in Orange ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results